Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
cRAF inhib
Welcome,
Profile
Billing
Logout
34 Companies
25 Products
25 Products
464 Diseases
705 Trials
34646 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
99
198
297
396
495
594
693
792
891
990
sorafenib
/ Generic mfg.
Stivarga
(regorafenib) / Bayer
Tafinlar
(dabrafenib) / Novartis
Zelboraf
(vemurafenib) / Roche
Braftovi
(encorafenib) / Pfizer
Zepsun
(donafenib) / Suzhou Zelgen
avutometinib
(VS-6766) / Verastem
Ojemda
(tovorafenib) / Day One Biopharma
naporafenib
(ERAS-254) / Erasca
belvarafenib
(RG6185) / Hanmi
lifirafenib
(BGB-283) / BeiGene
BMS-908662
/ Exelixis
APL-102
/ Apollomics
iCo-007
/ Ionis
AZ 628
/ AstraZeneca
BAL3833
/ Basilea
DCC-3084
/ Ono Pharma
HyNap-Sora
(sorafenib nanoparticle) / Xspray Pharma
JZP815
/ Jazz
LY3009120
/ Eli Lilly
QLH11906
/ Qilu Pharma
TR128
/ Tarapeutics Science
XP-102
/ Xynomic
exarafenib
(KIN-2787) / Pierre Fabre
